What Money Can't Buy: The Unique Offerings of Patient Group Investors

3:30 PM - 4:30 PM (EDT), Monday, June 5, 2023 ・ Session Room 252AB
How can patient advocacy groups attract an early-stage company to develop technology for their community? Amid a competitive, yet uncertain marketplace, how do companies decide which disease areas to target with their technologies? Making this decision with the right partners is critical, and early-stage companies should consider the tools, resources, and expertise that patient organizations can provide. Opportunities for connection and collaboration can be the difference between failure and success.

This session will provide examples of support beyond the dollar — such as clinical samples, patient registry data, and regulatory assistance — that can help supplement an investment to build fruitful relationships that lead to progress for the most vulnerable patients. This session will discuss the Cystic Fibrosis and Michael J. Fox Foundations’ collaborations with 4D Molecular Therapeutics and AbbVie, respectively.
Senior Science Editor
National Geographic
Executive Vice President and Chief Scientific Officer
Cystic Fibrosis Foundation
Chief Program Officer
The Michael J. Fox Foundation for Parkinson's Research
Vice President of Clinical Science and Therapeutic Area Head for Pulmonary
4D Molecular Therapeutics
Senior Medical Director in Neuroscience Clinical Development